Nirek Resources Inc.

March 10, 2008 02:00 ET

Nirek's Shareholders' Meeting-London, England

ONTARIO, CANADA--(Marketwire - March 10, 2008) - Nirek Resources Inc. ("Nirek") (FRANKFURT:3N6)(WKN:A0MTW5) and Gold Warrant (FRANKFURT:CA6546411175) (WKN:A0SW7M) is pleased to announce that a special meeting of shareholders' was held at the Holiday Inn (Brent Cross) in London, England on Sunday February 24, 2008.

This was an excellent opportunity for the shareholders based in the U.K. and Europe to meet the Board of Directors and its U.K representative. The meeting was open to all shareholders. Most shareholders were from the U.K. with additional attendees from Canada and Europe.

There were three major resolutions proposed and carried.

1. The issuance of common shares in order to acquire 10,000 ounces gold to back the Gold-Bullion-backed warrant introduced by the company in November 2007.

2. The facility to issue up to 20,000,000 common shares in private placements at a price of $1.25 Canadian per share.

3. An additional facility to issue up to 20,000,000 common shares in private placements at a rate to be determined by the directors at the time of issuance.

The above matters were transacted as preparation for the company's longer term financing and business plans.

Following the shareholders' meeting there was a detailed presentation focusing on the company's properties; the Eby-Otto Fault Zone, the Gosselin Veins and the Kirana Mine, the Gold-Bullion-backed warrant and the future of the Company.

A special thanks extended to Nirek's London office for an excellent effort in organizing the meeting and insuring that it was well-attended.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein which are not historical are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

Frankfurt Exchange: 3N6

Outstanding Shares: 16,952,220

Contact Information